COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

19/06/2017 - 14:48

Bagsværd, Denmark, 19 June 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Extrodinary General Shareholders' Meeting

19/06/2017 - 14:30

NEWS RELEASE IRVINE, CA, and HERSTAL, BELGIUM - 14:30 CEST, June 19 2017 - MDxHealth SA (Euronext: MDXH.BR) held today its Extraordinary General Shareholders' Meeting in Brussels. The shareholders approved all agenda [...]

Assemblée Générale Extraordinaire des Actionnaires

19/06/2017 - 14:30

COMMUNIQUE DE PRESSE IRVINE, CA, et HERSTAL, BELGIQUE, le 19 juin , 14:30 CEST - MDxHealth SA (Euronext: MDXH.BR) a tenu aujourd'hui son Assemblée Générale Extraordinaire des Actionnaires à Bruxelles. Les actionnaires [...]

Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting

19/06/2017 - 13:57

Seneffe, June 19, 2017. The Minutes and all relevant documents regarding the Annual General Meeting 2017 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About Eckert & [...]

Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale des actionnaires

19/06/2017 - 13:57

Seneffe, le 19 juin 2017. Le procès verbal ainsi que tous les documents relatifs à l'Assemblé Générale 2017 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/shareholder_information/ A [...]

Glepaglutide meets primary endpoint in Phase 2 trial in patients with short bowel syndrome

19/06/2017 - 09:59

Glepaglutide* is a novel long-acting GLP-2 analogue Reduction in fecal wet weight output of 30% and 23% in the two highest dose groups Increases in gastrointestinal fluid and energy absorption observed The dose response [...]

187,133 Orion Corporation A shares converted into B shares

19/06/2017 - 09:50

ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2017 at 10.50 a.m. EEST 187,133 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 187, [...]

Diaxonhit : Nouvelle composition du conseil de surveillance

19/06/2017 - 07:30

Nouvelle composition du conseil de surveillance de DIAXONHIT Jean-Pierre HERMET est nommé président du conseil de surveillance Patrick de ROQUEMAUREL est nommé membre du conseil de surveillance Démissions de Laurent [...]

Sandoz receives approval in Europe for Rixathon® (biosimilar rituximab) to treat blood cancers and immunological diseases

19/06/2017 - 07:15

European Commission approves Sandoz Rixathon ® to treat blood cancers and immunological diseases. Approval expected to broa den patient access to biologics and enable budget-constrained healthcare systems to reallocate [...]

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

19/06/2017 - 07:00

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, June 19, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a scientific agreement with [...]

MDxHealth et l'Université de technologie du Queensland collaborent sur un test de biopsie liquide pour le dépistage de cancer buccal

19/06/2017 - 07:00

COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 AM CEST - Le 19 juin 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui qu'il a signé un [...]

Medtronic Exclusive Reactive ATP(TM) Therapy Slows Progression of Atrial Fibrillation in Real-World Patient Population

18/06/2017 - 15:00

Data Presented as Late Breaking Clinical Trial at EUROPACE 2017 DUBLIN and VIENNA - June 18, 2017 - Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc (NYSE: [...]

DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress

17/06/2017 - 08:30

Press Release Montrouge, France, June 17, 2017 DBV Technologies Highlights Poster Presentations on EPIT ® at the 2017 EAACI Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]

DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT®) au Congrès de l'EAACI 2017

17/06/2017 - 08:30

Communiqué de Presse Montrouge, France, 17 juin 2017, 8h30 CEST DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT ® ) au Congrès de l'EAACI 2017 DBV Technologies (Euronext : DBV - ISIN : [...]

Novartis International AG: New patient survey highlights need for more action to help severe asthma patients gain control of their disease

17/06/2017 - 07:15

Large-scale European patient survey found that 94% of severe allergic asthma patients were unable to fully control their disease These new data underscore the disconnect between self-perceived control and clinical [...]

GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017

16/06/2017 - 17:46

GENFIT : resultats de l'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017 - Approbation du changement du mode d'administration de la Société - Nomination du Président-Directeur Général et des Comités du [...]

GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017

16/06/2017 - 17:46

GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017 - Approval of the change in mode of administration and management of the Company - Nomination of the Chairman and CEO and the [...]

Diaxonhit : Assemblée générale ordinaire et extraordinaire annuelle

16/06/2017 - 17:45

Assemblée générale ordinaire et extraordinaire annuelle de Diaxonhit Les actionnaires ont adopté toutes les résolutions à titre ordinaire et à titre extraordinaire agréées par le directoire Paris, France - 16 juin 2017 [...]

FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update

16/06/2017 - 14:28

Bagsværd, Denmark, 16 June 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has published the briefing documents ahead of the Advisory Committee meeting to discuss the supplemental New [...]